Skip to main content
Premium Trial:

Request an Annual Quote

Growing the Personalized Medicine Market

At Cross Border Biotech, Jeremy Grushcow discusses the stumbling blocks to realizing the 11 percent annual growth rate predicted by PricewaterhouseCoopers for personalized medicine. First, he says, healthcare providers need to learn new approaches and a new language, but, he adds, that “doesn’t mean that the market will grow.” Plus, there are gaps in GINA that could give people pause. “GINA does not expressly cover long-term care and other types of insurance and is focused to some extent on prohibitions on requiring genetic tests,” Grushcow says. The PricewaterhouseCoopers report itself says that pharmaceutical companies would have to rethink their blockbuster drug model and instead consider “a more collaborative model focused on outcomes and specialized therapies.”

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.